Monroe Bank & Trust’s Novartis NVS Stock Holding History

Monroe Bank & Trust’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-223	Closed	-$15K	–	192
2018 Q2	$15K	Hold	223	–	–	﹤0.01%	202
2018 Q1	$16K	Hold	223	–	–	0.01%	204
2017 Q4	$17K	Buy	+223	New	+$16.8K	0.01%	202
2017 Q3	–	Sell	-223	Closed	-$17K	–	207
2017 Q2	$17K	Hold	223	–	–	0.01%	206
2017 Q1	$15K	Hold	223	–	–	0.01%	214
2016 Q4	$15K	Buy	+223	New	+$14.5K	0.01%	221
2016 Q2	–	Sell	-1,032	Closed	-$67K	–	255
2016 Q1	$67K	Sell	1,032 -419	-29%	-$28.5K	0.02%	162
2015 Q4	$112K	Hold	1,451	–	–	0.04%	143
2015 Q3	$119K	Hold	1,451	–	–	0.04%	143
2015 Q2	$128K	Hold	1,451	–	–	0.04%	139
2015 Q1	$128K	Sell	1,451 -837	-37%	-$74.2K	0.04%	142
2014 Q4	$190K	Buy	+2,288	New	+$190K	0.06%	136
2014 Q3	–	Sell	-2,288	Closed	-$185K	–	226
2014 Q2	$185K	Sell	2,288 -251	-10%	-$19.7K	0.06%	145
2014 Q1	$193K	Sell	2,539 -1,174	-32%	-$85.5K	0.06%	149
2013 Q4	$267K	Sell	3,713 -245	-6%	-$17K	0.1%	119
2013 Q3	$272K	Sell	3,958 -6,324	-62%	-$418K	0.11%	119
2013 Q2	$652K	Buy	+10,282	New	+$669K	0.29%	79

Other funds holding NVS

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

BBHC

Brown Brothers Harriman & Co New York $22.8B AUM 25.09% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Monroe Bank & Trust's NVS Position: Q3 2018 in Review

Monroe Bank & Trust sold out of Novartis (NVS) in Q3 2018, closing a stake of 223 shares — an estimated $15K sold.

Monroe Bank & Trust first reported a position in NVS in Q2 2013 and held it in 17 quarters. The position peaked at $652K in Q2 2013. 1,028 funds tracked by Wall St. Rank hold NVS as of Q3 2018.

Monroe Bank & Trust reported no remaining Novartis position as of Q3 2018 after selling out during the quarter.
Monroe Bank & Trust sold 223 Novartis shares in Q3 2018, an estimated $15K.
Monroe Bank & Trust first reported a position in Novartis in Q2 2013 and held it in 17 quarters.
Monroe Bank & Trust's Novartis position peaked at $652K in Q2 2013.
1,028 funds tracked by Wall St. Rank held Novartis as of Q3 2018.

Based on Monroe Bank & Trust's 13F filing for Q3 2018, filed 14 Nov 2018.